Skip to main content
logo
Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5780
+0.0074 (1.30%)
Oct 19, 2026, 1:34 PM EST

Arch Biopartners Financials Overview

Millions CAD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
-0.282.121.980.963.89
Revenue Growth
--87.00%6.97%105.63%-75.18%5625.22%
Gross Profit
-0.740.07-1.66-0.13-0.5-0.15
Operating Income
-2.47-1.13-3.46-2.9-1-0.82
Net Income
-2.83-1.55-3.92-3.33-1.41-1.17
Earnings Per Share
-0.04-0.02-0.06-0.05-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
0000.830.510.45
Total Debt
2.732.842.775.024.415.16
Net Cash (Debt)
-2.72-2.84-2.77-4.18-3.91-4.72
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.04-0.07-0.06-0.08

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-1.72-1.58-2.33-0.230.48-2.98
Free Cash Flow
-1.72-1.58-2.33-0.230.48-2.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
-24.44%-78.05%-6.50%-52.13%-3.85%
Operating Margin
--411.11%-162.86%-145.99%-103.36%-21.08%
Pretax Margin
--562.70%-184.76%-167.71%-145.94%-30.10%
Profit Margin
--562.70%-184.76%-167.71%-145.94%-30.10%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
-308.4653.5134.58193.3927.41